Sign in

CIK 0001447028 · Non-accelerated filer<br>Smaller reporting company

Arbutus Biopharma Corp

Sign in to watch
Ticker
ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
EIN
980597776
Phone
604-419-3200
Business address
701 VETERANS CIRCLE, WARMINSTER, PA, 18974
Former names
TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award General Counsel and CCO acquired 95,100 shares (grant or award)
  3. 4 Planned sale Chief Medical Officer sold 4,358 shares at $2.31 ($10,078)
  4. 4 Planned sale Chief Financial Officer sold 9,593 shares at $2.31 ($22,184)
  5. 4 Planned sale Chief Scientific Officer sold 9,982 shares at $2.31 ($23,083)
  6. 4 Planned sale Interim President & CEO sold 10,164 shares at $2.31 ($23,504)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Chief Business Officer acquired 83,700 shares (grant or award)
  19. 4 Grant or award Chief Scientific Officer acquired 82,200 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 79,000 shares (grant or award)

Page 3 of 14 · 274 filings